Transferability of the mcr-1 Colistin Resistance Gene by Dénervaud Tendon, Valérie et al.
Transferability of the mcr-1 Colistin Resistance Gene
Vale´rie De´nervaud Tendon,1–3 Laurent Poirel,1–3 and Patrice Nordmann1–4
Keywords: antibiotic, resistance, MCR-1, polymyxins, colistin, Enterobacteriaceae
Polymyxins (colistin, polymyxin B) are last-resortantibiotics for treating infections with carbapenem-
resistant bacteria. Therefore, the frequency of its use in
hospital settings is on the rise worldwide. Until recently,
acquired resistance to colistin was mainly due to chromo-
somal alterations of pathways involved in modiﬁcation of
the bacterial outer membrane components (lipopolysaccha-
rides).1,2 However, the plasmid-mediated colistin resistance
gene, mcr-1, has been recently reported worldwide after its
ﬁrst identiﬁcation in Enterobacteriaceae from the environ-
ment, animals, and humans in China.3 The aim of this study
was therefore to determine to which frequencies plasmids
carrying the mcr-1 gene could be transferred by conjugation
among enterobacterial species.
Three MCR-1-producing clinical isolates were used as
donors in mating-out experiments.4 Escherichia coli strains
Af24, Af31, and Af48 possessed plasmids of various sizes
and incompatibility groups (Table 1). Mating-out assays
were performed in triplicate onto Luria–Bertani (LB) agar
plate, using a 1:10 donor to recipient ratio, as described
elsewhere.5 Transconjugants E. coli J53 were selected on LB
agar plates containing colistin (1mg/ml) and azide (100mg/
ml). Transfer frequencies were calculated as the number of
transconjugants obtained per donor. E. coli J53 transconju-
gants carrying the mcr-1 plasmids were obtained, namely
Tc24, Tc31, and Tc48 (Table 1). Those plasmids were self-
conjugative, although the frequency was relatively low,
ranging from 10-6 to 10-7 transconjugants/donor (Table 1).
These frequencies were much lower than the transfer rate
reported in the pioneer work (10-1 to 10-3) from E. coli
SHP45 to E. coli C600, when determined with a 64-kb IncI2-
type plasmid. Although E. coli Af24 harbored a plasmid of
approximately the same size than that of an IncI2-type found
in E. coli SHP45 described in the original study reporting
MCR-1,3 transfer frequency was at least 1,000-fold lower.
The size and the incompatibility group of the mcr-1-positive
plasmids did not modify their transfer rate. The IncX4
plasmid was slightly less conjugative, with a frequency ob-
served at 7.5– 1.9· 10-7, despite its smaller size (30 kb).
Conjugation frequencies were also determined without the
inﬂuence of the chromosomal background of the donor
(clinical isolate), using the three isogenic MCR-1-positive
E. coli J53 as donors, and E. coli ST69 (nalidixic acid resistant),
Klebsiella pneumoniae CIP53153, Klebsiella oxytoca R192,
a series of Enterobacter cloacae recipient strains including
E. cloacae CIP103624, and strains Enc1 to Enc5, and two En-
terobacter aerogenes strains R232 and R233. The experiments
were performedby plating the conjugationmixture ontoLBagar
plates supplemented with colistin (1mg/ml) and nalidixic acid
(20mg/ml) or ampicillin (100mg/ml). The transfer rates of the
MCR-1-encoding plasmids ranged from 10-5 to 10-6 in E. coli,
from 10-5 to 10-6 in K. pneumoniae, from 10-4 to 10-5 in
K. oxytoca, and 10-7–10-8 inE. cloacae (Table 2). Those results
correspond to common conjugation frequencies for antibiotic
resistance plasmids in Enterobacteriaceae, being often in the
range from 10-5 to 10-6. The E. coli transconjugants had mini-
mal inhibitory concentration (MIC) values of colistin at 8–16mg/
ml forE. coli and at 32–64mg/ml forKlebsiella spp. compared to
0.25mg/ml for the recipient strains (Table 3). The higher MIC
values obtained in Klebsiella spp. may be related to differential
gene expression or different protein functionality in those two
enterobacterial species.
Table 1. Plasmid Features of the Three MCR-1-Positive E. coli Clinical Isolates
and Their Conjugative Frequencies in E. coli J53
Isolate (ST type) Plasmid name Plasmid size (kb) Incompatibility group Conjugative frequency in E. coli J53
E. coli Af24 (ST1007) Af24 70 IncI2 6.7 – 3.9 · 10-6
E. coli Af31 (ST624) Af31 150 IncHI2 2.2 – 1.7 · 10-6
E. coli Af48 (ST624) Af48 30 IncX4 7.5 – 1.9 · 10-7
Standard deviation was calculated from three independent cultures.
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Since the occurrence of the mcr-1 gene was reported in
E. cloacae,6 and since our preliminary experiments indicated
failed to detect conjugation into that species, we conducted
additional experiments to evaluate the conjugation efﬁciency
in additional strain backgrounds. Six E. cloacae and two
E. aerogenes strains were therefore tested as recipients. A very
low conjugation frequency (between 10-7 and 10-8 depending
on the strains) was obtained with the different E. cloacae
recipient strains. A higher conjugation rate was found with
the different E. aerogenes strains (between 10-3 and 10-4).
The transfer frequency of the IncI2-type plasmid carrying
the mcr-1 gene reported in the pioneer study was surpris-
ingly high, ranging from 10-1 to 10-3 from E. coli to E. coli.
Here our results do not support those latter observations,
with conjugation frequencies being lower in the different
enterobacterial backgrounds used. Regardless of their in-
compatibility types, plasmids carrying the mcr-1 gene could
be transferred to several enterobacterial species (at least to
E. coli, K. pneumoniae, K. oxytoca, and E. aerogenes) at a
conjugation rate varying from 10-4 to 10-6.
The study further conﬁrms that the mcr-1 gene may efﬁ-
ciently spread among most enterobacterial species, with vari-
able frequencies depending on the recipient strains/species,
rather than on the plasmid types. Low rates of transconjugants
obtained in E. cloacaemight be linked to a deleterious effect of
mcr-1 gene expression in that species, considering that MCR-1
is a phosphoethanolamine transferase modifying the lipopoly-
saccharides structure, thereforemodifying the bacterial surface.
There is a need to monitor the spread of the mcr-1 gene
between E. coli on one hand and multidrug-resistant
K. pneumoniae strains on the other hand, since it may
possibly give rise to pandrug-resistant isolates such as those
producing MCR-1 and carbapenemases.7
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Table 3. MIC Values of Colistin (mg/ml) for E. coli Clinical Strains
and Transconjugants Producing MCR-1
Plasmid
Clinical strain E. coli J53 Tc E. coli J53 E. coli ST69
K. pneumoniae CIP53153 K. oxytoca R192Donor Transconjugant Donor Transconjugant
Af24 8 8 8 8 32 64
Af31 8 8 8 16 64 64
Af48 8 8 8 8 32 64
All recipient strains have a minimal inhibitory concentration (MIC) value of 0.25mg/ml for colistin.
Table 2. Conjugative Transfer Frequencies of mcr-1-Positive E. coli J53
Transconjugants to E. coli ST69, Klebsiella pneumoniae CIP53153, Klebsiella oxytoca R192
Enterobacter cloacae CIP103624, and Enterobacter aerogenes R232
E. coli ST69 K. pneumoniae CIP53153 K. oxytoca R192 E. cloacae CIP103624 E. aerogenes R232
Tc24 2.8 – 1.7 · 10-5 6.0 – 7.4 · 10-6 1.2 – 0.43 · 10-4 10-7 1.3 – 0.43 · 10-3
Tc31 5.6 – 3.8 · 10-6 6.5 – 1.4 · 10-5 1.9 – 3.3 · 10-4 10-7 1 – 1.8 · 10-4
Tc48 4.9 – 2.3 · 10-5 1.7 – 0.41 · 10-6 2.8 – 4.3 · 10-5 10-7 5.7 – 5 · 10-3
Standard deviation was calculated from three independent cultures.
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